TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
ACHIM Biotherapeutics AB
Closing information (x1000 EUR)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
0
|
0
|
79 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-17
|
-28
|
9 |
| EBITDA |
-17
|
-28
|
9 |
| Total assets |
13
|
21
|
59 |
| Current assets |
13
|
21
|
59 |
| Current liabilities |
6
|
7
|
11 |
| Equity capital |
7
|
15
|
47 |
| - share capital |
13
|
13
|
14 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
53.8%
|
71.4%
|
79.7% |
| Turnover per employee |
0
|
0
|
79 |
| Profit as a percentage of turnover | 11.4% | ||
| Return on assets (ROA) |
-130.8%
|
-133.3%
|
15.3% |
| Current ratio |
216.7%
|
300%
|
536.4% |
| Return on equity (ROE) |
-242.9%
|
-186.7%
|
19.1% |
| Change turnover |
0
|
-72
|
-12 |
| Change turnover % |
-100%
|
-13% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.